Literature DB >> 28701263

Treatment for anal fissure: Is there a safe option?

Justin T Brady1, Alison R Althans2, Ruel Neupane3, Eslam M G Dosokey4, Murad A Jabir4, Harry L Reynolds3, Scott R Steele3, Sharon L Stein5.   

Abstract

BACKGROUND: Surgeons often approach anal fissure with chemical denervation (Botulinum toxin, BT) instead of initial lateral internal sphincterotomy (LIS) due to concerns for long-term incontinence. We evaluated the characteristics and outcomes of patients who received BT or LIS.
METHODS: We performed a retrospective chart review of patients undergoing LIS and BT for anal fissure between 2009 and 2015. In 2015, a telephone survey was performed to evaluate durability, long-term incontinence and patient satisfaction.
RESULTS: Ninety-four patients met criteria: 73 LIS and 21 BT. Age (BT 49 vs. LIS 52) was similar between groups (p = 1.0). Cleveland Clinic Fecal Incontinence (CCFI) score pre-intervention was higher in BT than LIS patients (2.1 vs. 0.4, p = 0.007) with fewer BT patients with perfect continence (50% vs. 88%). Telephone survey response was 61%. Fissure recurrence was significantly higher for BT than LIS patients (36% vs. 9%, p = 0.03).
CONCLUSION: Patients undergoing LIS were less likely to recur. Both LIS and BT patients had some durable changes in continence raising the question of whether there is a safe technique.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anal fissure; Anorectal disease; Sphincterotomy

Mesh:

Substances:

Year:  2017        PMID: 28701263     DOI: 10.1016/j.amjsurg.2017.06.004

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  1 in total

1.  Therapeutic properties of botulinum toxin on chronic anal fissure treatment and the patient factors role.

Authors:  Setareh Soltany; Hamid Reza Hemmati; Jafar Alavy Toussy; Dina Salehi; Parisa Alavi Toosi
Journal:  J Family Med Prim Care       Date:  2020-03-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.